DAPASUG-VD 5/50 TABS
DIASAGE
FeaturedTop

DAPASUG-VD 5/50 TABS

MRP: 1,750

Packaging: 10x10

Pack Type: tablet

Composition:

Dapagliflozin 5mg + Vildagliptin 50mg

Indication:

TYPE 2 DIABETES

Description:

Dapagliflozin 5mg + Vildagliptin 50mg is a dual-action oral antidiabetic medication indicated for the management of type 2 diabetes mellitus in adults. This fixed-dose combination works through complementary mechanisms:

  • Dapagliflozin is an SGLT2 inhibitor that helps lower blood glucose by preventing glucose reabsorption in the kidneys, promoting its excretion in urine.

  • Vildagliptin is a DPP-4 inhibitor that enhances the levels of incretin hormones, which increases insulin secretion and suppresses glucagon release.

The combination is effective in improving glycemic control, reducing HbA1c, and supporting weight loss, while maintaining a low risk of hypoglycemia when not combined with insulin or sulfonylureas. It is typically used alongside diet and exercise as part of a comprehensive diabetes treatment plan.

Tags:

Type 2 Diabetes Oral Antidiabetics Combination Therapy SGLT2 Inhibitor DPP-4 Inhibitor Prescription Medicine
  • Dual mechanism of action for enhanced blood glucose control
  • Reduces HbA1c, fasting and postprandial glucose levels
  • Promotes weight loss and reduces blood pressure
  • Low risk of hypoglycemia when used as monotherapy
  • Convenient once-daily oral dosage
  • Improves beta-cell function and insulin sensitivity

Usage Information

Dosage

Typical Dose: One tablet once daily or as prescribed by your physician Route: Oral With or Without Food: Can be taken regardless of meals Note: Do not skip or exceed the prescribed dose. Monitor blood glucose regularly.

Side Effects

Urinary tract infections Increased urination Genital fungal infections Headache Nausea Dizziness Hypoglycemia (especially with other antidiabetics) Dehydration or low blood pressure Seek immediate medical help if you experience allergic reactions, signs of urinary infection, or symptoms of ketoacidosis.

Contraindications

Type 1 diabetes mellitus Diabetic ketoacidosis Severe renal impairment or end-stage kidney disease Known hypersensitivity to Dapagliflozin, Vildagliptin, or any excipient Liver disease (use with caution) History of pancreatitis